Trellus Health plc

TRLS.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Market Cap£1,061£6,682£19,519£84,677
- Cash£4,344£12,166£19,085£31,982
+ Debt£0£0£0£0
Enterprise Value-£3,283-£5,484£434£52,695
Revenue£114£19£18£25
% Growth500%5.6%-28%
Gross Profit£114£19£18£25
% Margin100%100%100%100%
EBITDA-£7,161-£6,497-£8,274-£5,870
% Margin-6,281.6%-34,194.7%-45,966.7%-23,480%
Net Income-£7,782-£6,339-£8,810-£5,902
% Margin-6,826.3%-33,363.2%-48,944.4%-23,608%
EPS Diluted-0.048-0.039-0.055-0.045
% Growth-23%28.1%-21.7%
Operating Cash Flow-£7,321-£5,274-£8,620-£4,772
Capital Expenditures-£540-£2,351-£2,908-£3,721
Free Cash Flow-£7,861-£7,625-£11,528-£8,493
Trellus Health plc (TRLS.L) Financial Statements & Key Stats | AlphaPilot